BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/4/2020 9:56:59 AM | Browse: 446 | Download: 1036
 |
Received |
|
2020-06-16 15:04 |
|
Peer-Review Started |
|
2020-05-15 08:14 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-08-08 04:29 |
|
Revised |
|
2020-08-18 14:45 |
|
Second Decision |
|
2020-10-23 11:07 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-10-26 04:42 |
|
Articles in Press |
|
2020-10-26 04:42 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-10-31 23:58 |
|
Typeset the Manuscript |
|
2020-12-01 07:13 |
|
Publish the Manuscript Online |
|
2020-12-04 09:56 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Case Report |
| Article Title |
Neoadjuvant targeted therapy for apocrine carcinoma of the breast: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ping Yang, Shu-Jia Peng, Yan-Ming Dong, Lin Yang, Zhen-Yu Yang, Xi-E Hu and Guo-Qiang Bao |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Guo-Qiang Bao, MD, Assistant Professor, Associate Chief Physician, Doctor, Surgeon, Department of General Surgery, Tangdu Hospital, Air Force military medical university, No. 569, Xinsi Road, Xi’an 710032, Shaanxi Province, China. guoqiang@fmmu.edu.cn |
| Key Words |
Breast neoplasm; ErbB-2 receptor; Targeted therapy; Case report; Apocrine gland; Neoadjuvant therapies |
| Core Tip |
A woman with apocrine carcinoma of the left breast who underwent core needle biopsy. The patient was diagnosed with apocrine carcinoma by immunohistochemical staining, and negative hormone status (estrogen receptor and progesterone receptor), but showed overexpression of human epidermal factor receptor 2 (HER-2). Moreover, positive expression of androgen receptor (AR, approximately 60%) and gross cystic disease fluid protein 15 was observed. The patient was treated with neoadjuvant targeted therapy consisting of the TCH (docetaxel, carboplatin area under curve 6 and trastuzumab) regimen every 21 d. The mass in the left breast was significantly reduced, and pain in the breast and left upper arm also improved. |
| Publish Date |
2020-12-04 09:56 |
| Citation |
Yang P, Peng SJ, Dong YM, Yang L, Yang ZY, Hu XE, Bao GQ. Neoadjuvant targeted therapy for apocrine carcinoma of the breast: A case report. World J Clin Cases 2020; 8(23): 6036-6042 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i23/6036.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i23.6036 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
